These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


556 related items for PubMed ID: 20409679

  • 1. Cryoplasty as endovascular treatment in the femoropopliteal region: hemodynamic results and follow-up at one year.
    Gonzalo B, Solanich T, Bellmunt S, Herranz C, González E, Arnedo G, Muñoz G, Florit S, Hospedales J, Lloret MD, Vallespín J, Giménez A.
    Ann Vasc Surg; 2010 Jul; 24(5):680-5. PubMed ID: 20409679
    [Abstract] [Full Text] [Related]

  • 2. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
    Han DK, Shah TR, Ellozy SH, Vouyouka AG, Marin ML, Faries PL.
    Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
    [Abstract] [Full Text] [Related]

  • 3. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K, Gable D, Pearl G, Theune B, Black S.
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [Abstract] [Full Text] [Related]

  • 4. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E, Marks NA, Hingorani AP, Schutzer RW, Mutyala M.
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [Abstract] [Full Text] [Related]

  • 5. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
    Torres-Blanco Á, Edo-Fleta G, Gómez-Palonés F, Molina-Nácher V, Ortiz-Monzón E.
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
    [Abstract] [Full Text] [Related]

  • 6. Single-center experience in endovascular treatment for infrainguinal bypass obstructions.
    Baumann F, Engelberger RP, Makaloski V, Do DD, Baumgartner I, Diehm N.
    J Vasc Interv Radiol; 2012 Aug; 23(8):1055-62. PubMed ID: 22840804
    [Abstract] [Full Text] [Related]

  • 7. Endovascular interventions for TASC II D femoropopliteal lesions.
    Baril DT, Chaer RA, Rhee RY, Makaroun MS, Marone LK.
    J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
    [Abstract] [Full Text] [Related]

  • 8. Femoral-popliteal bypass with endoscopically harvested saphenous vein in patients with TASC D disease of the superficial femoral artery.
    Hines GL, Wain RA, Montecalvo J, Feuerman M.
    Ann Vasc Surg; 2010 Jul; 24(5):615-20. PubMed ID: 19892513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF, Mezzetto L, Macrì M, Criscenti P, Corvasce A, Poli R.
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [Abstract] [Full Text] [Related]

  • 14. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A, Abdel-Hamid M, Ewida A, Saad M, Sahrabi A.
    Vascular; 2010 Feb; 18(2):71-6. PubMed ID: 20338130
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M.
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.